Cleared Traditional

K910419 - BIOCLONE'S ELEGANCE IGE ELISA KIT

K910419 is an FDA 510(k) clearance for BIOCLONE'S ELEGANCE IGE ELISA KIT, manufactured by Bioclone Australia Pty , Ltd.. The device is a Class 2 Immunology device with product code DGC cleared through the Traditional 510(k) pathway after a 142-day FDA review.

K910419 · Bioclone Australia Pty , Ltd. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1991
Decision
142d
Days
Class 2
Risk

K910419 is an FDA 510(k) clearance for the BIOCLONE'S ELEGANCE IGE ELISA KIT. Classified as Ige, Antigen, Antiserum, Control (product code DGC), Class II - Special Controls.

Submitted by Bioclone Australia Pty , Ltd. (Washington, US). The FDA issued a Cleared decision on June 21, 1991 after a review of 142 days - within the typical 510(k) review window.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5510 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Bioclone Australia Pty , Ltd. devices

FDA 510(k) Submission Details - K910419

510(k) Number K910419 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 30, 1991
Decision Date June 21, 1991
Days to Decision 142 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
37d slower than avg
Panel avg: 105d · This submission: 142d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DGC Device Classification - Class 2, Special Controls

Product Code DGC Ige, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DGC Ige, Antigen, Antiserum, Control

All 91
Devices cleared under the same product code (DGC) and FDA review panel - the closest regulatory comparables to K910419.
IGE ENZYME IMMUNOASSAY TEST KIT CAT.NO. KIF4064
K922047 · Medix Biotech, Inc. · Aug 1992
ACS TOTAL IGE IMMUNOASSAY
K920372 · Ciba Corning Diagnostics Corp. · Apr 1992
KALLESTEAD TOTAL IGE MICROPLATE KIT
K912800 · Bio-Rad Laboratories, Inc. · Jul 1991
PHARMACIA SPECIFIC IGE CONTROL
K911631 · Pharmacia, Inc. · Apr 1991
POSITIVE CONTROL PAD FOR TOTAL IGE TEST DIPSTICK
K910082 · Quidel Corp. · Mar 1991
VENTREX COATED TUBE IGE RADIOIMMUNOASSAY
K905612 · Ventrex Laboratories, Inc. · Feb 1991